Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024)

Historic Non-Current Debt for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2024 value amounting to $56.2 million.

  • Organogenesis Holdings' Non-Current Debt fell 960.12% to $56.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $56.2 million, marking a year-over-year decrease of 960.12%. This contributed to the annual value of $60.7 million for FY2023, which is 828.31% down from last year.
  • Per Organogenesis Holdings' latest filing, its Non-Current Debt stood at $56.2 million for Q3 2024, which was down 960.12% from $57.7 million recorded in Q2 2024.
  • Over the past 5 years, Organogenesis Holdings' Non-Current Debt peaked at $74.5 million during Q3 2021, and registered a low of $37.3 million during Q2 2021.
  • In the last 5 years, Organogenesis Holdings' Non-Current Debt had a median value of $60.7 million in 2023 and averaged $60.3 million.
  • Per our database at Business Quant, Organogenesis Holdings' Non-Current Debt plummeted by 2958.04% in 2021 and then soared by 8495.31% in 2022.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Non-Current Debt stood at $60.0 million in 2020, then increased by 17.95% to $70.8 million in 2021, then decreased by 6.41% to $66.2 million in 2022, then dropped by 8.28% to $60.7 million in 2023, then decreased by 7.56% to $56.2 million in 2024.
  • Its last three reported values are $56.2 million in Q3 2024, $57.7 million for Q2 2024, and $59.4 million during Q1 2024.